J H Jacob

1.3k citations

27 papers · 915 indexed · h-index 14

Surgery top 10%
Pulmonary and Respiratory Medicine top 5%
Oncology top 5%
Molecular Biology
Hepatology top 10%

Co-authors: Jean‐Luc Raoul B Paillot Harry Bleiberg Yacine Merrouche Étienne Dorval Érick Gamelin Alain Morel Laurent Bedenne
Topics: Colorectal Cancer Treatments and Studies (12 papers)Gastric Cancer Management and Outcomes (11 papers)Esophageal Cancer Research and Treatment (11 papers)
Cited by: Oncology Pulmonary and Respiratory Medicine Surgery
Journals: Journal of Clinical Oncology British Journal of Cancer International Journal of Radiation Oncology*Biology*Physics
Partner nations: France Luxembourg Belgium

In The Last Decade

J H Jacob

27 papers receiving 887 citations

Peers

Countries citing papers authored by J H Jacob

Since Specialization

Citations

This map shows the geographic impact of J H Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J H Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J H Jacob more than expected).

Fields of papers citing papers by J H Jacob

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J H Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J H Jacob. The network helps show where J H Jacob may publish in the future.

Co-authorship network of co-authors of J H Jacob

This figure shows the co-authorship network connecting the top 25 collaborators of J H Jacob. A scholar is included among the top collaborators of J H Jacob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J H Jacob. J H Jacob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PCN100 COST-EFFECTIVENESS OF GEFITINIB VERSUS DOUBLET CHEMOTHERAPY IN FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) IN SWEDEN 2010 ·Value in Health ·J H Jacob,Martin Henriksson,Daniel Brattström	3
2	A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5–FU2 + irinotecan or LV5–FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer 2007 ·Annals of Oncology ·Y. Bécouarn,Pierre Sénesse,Simon Thézenas,Éveline Boucher,Antoine Adenis,Laurent Cany,J H Jacob,F. Cvitkovic,C. Montoto-Grillot,Marc Ychou	11
3	Preoperative Treatment Combining Capecitabine with Radiation Therapy in Rectal Cancer: A GERCOR Phase II Study 2007 ·Oncology ·Olivier Dupuis,Brigitte Vié,Gérard Lledo,Christophe Hennequin,Monique Noirclerc,(unknown),J H Jacob	24
4	CETUFTIRI, a new combination of UFT with leucovorin (LV), irinotecan, and cetuximab as first-line treatment for patients (pts) with unresectable metastatic colorectal cancer (mCRC): Preliminary results from a multicenter phase II trial 2007 ·Journal of Clinical Oncology ·Jaafar Bennouna,Roger Faroux,Emmanuel Jean Francois,(unknown),(unknown),Hervé Perrier,J H Jacob,Françoise Desseigne,G. Perrocheau,Jean‐Yves Douillard	2
5	Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial 2006 ·British Journal of Cancer ·Pierre Michel,Antoine Adenis,F. Di Fiore,Éveline Boucher,Marie‐Pierre Galais,Laëtitia Dahan,X. Mirabel,H. Hamidou,Jean‐Luc Raoul,J H Jacob,M F Hellot,(unknown),B Paillot	38
6	Esophagus cancer 2006 ·Gastroentérologie Clinique et Biologique ·Jean‐François Seitz,Laëtitia Dahan,J H Jacob,(unknown),P. Maingon,Laurent Bedenne,Jean–Pierre Triboulet	2
7	‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer’ 2005 ·British Journal of Cancer ·Jaafar Bennouna,Hervé Perrier,B Paillot,Frank Priou,J H Jacob,Mohamed Hebbar,Sylvain Bordenave,J.F. Seitz,F. Cvitkovic,Étienne Dorval,(unknown),(unknown),Jean‐Yves Douillard	20
8	Capecitabine (X) chemoradiation (CRT) in the preoperative treatment of patients (pts) with rectal adenocarcinomas: A phase II GERCOR trial 2004 ·Journal of Clinical Oncology ·Olivier Dupuis,Brigitte Vié,Gérard Lledo,C. Hennequin,Monique Noirclerc,Mohammed Bennamoun,(unknown),J H Jacob	4
9	Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer 2003 ·Annals of Oncology ·David Fallik,Marc Ychou,J H Jacob,Philippe Colin,Jean‐François Seitz,J Baulieux,Antoine Adenis,Jean‐Yves Douillard,Patrice Couzigou,(unknown),Michel Ducreux,M. Mahjoubi,Philippe Rougier	22
10	High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer 2002 ·Cancer Chemotherapy and Pharmacology ·Marc Ychou,Jean‐Luc Raoul,Françoise Desseigne,Christian Borel,François‐Xavier Caroli‐Bosc,J H Jacob,J. F. Seitz,A. Kramar,(unknown),(unknown),C. Couteau,Yacine Merrouche	40
11	Carcinoma of the oesophagus 2001 ·British Journal of Cancer ·Jean‐François Seitz,(unknown),Éric François,J H Jacob,(unknown),P. Rougier,Alexandre Roussel	2
12	Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus 2001 ·European Journal of Cancer ·Th. Wobbes,B. Barón,B Paillot,J H Jacob,P Haegèle,M Gignoux,Pierre Michel,(unknown)	30
13	Localized squamous-cell cancer of the esophagus: retrospective analysis of three treatment schedules 2001 ·Radiotherapy and Oncology ·Corinne Delcambre,J H Jacob,Didier Pottier,M Gignoux,(unknown),Brigitte Vié,Alexandre Roussel,P Ségol	16
14	Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer 1997 ·European Journal of Cancer ·Harry Bleiberg,Thierry Conroy,B Paillot,A.J. Lacave,G.H. Blijham,J H Jacob,Laurent Bedenne,M. Namer,Pietro De Besi,Francesca Gay,Laurence Collette,Tarek Sahmoud	235
15	Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group. 1996 ·Journal of Clinical Oncology ·Thierry Conroy,Pierre-Luc Etienne,Antoine Adenis,(unknown),B Paillot,Éric François,Laurent Bedenne,J H Jacob,Jean‐François Seitz,Harry Bleiberg,C van Pottelsberghe,M. van Glabbeke,F.M. Delgado,(unknown),J. Wils	68
16	Prevalence survey of precancerous lesions of the oesophagus in a high-risk population for oesophageal cancer in France 1993 ·European Journal of Cancer Prevention ·J H Jacob,Aart Brutel de la Rivière,A.M. Mandard,Nicolás Muñoz,M. Crespi,Y Etienne,Xavier Castellsagué,(unknown),(unknown),(unknown)	11
17	Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: Final results of a controlled clinical trial 1989 ·International Journal of Radiation OncologyBiologyPhysics ·Alexandre Roussel,Harry Bleiberg,O. Dalesio,J H Jacob,P Haegèle,Geena Jung,B Paillot,(unknown),M Gignoux,(unknown),(unknown),Marc Buyse,N. Duez	32
18	Controlled Clinical Trial for the Treatment of Patients with Inoperable Esophageal Carcinoma: A Study of the EORTC Gastrointestinal Tract Cancer Cooperative Group 1988 ·Recent results in cancer research ·Alexandre Roussel,J H Jacob,P Haegèle,Geena Jung,B Paillot,(unknown),M Gignoux,(unknown),(unknown),Harry Bleiberg,Marc Buyse,Otilia Dalesio,N. Duez	16
19	[Screening for cancer of the upper aerodigestive tract in a high-risk population]. 1985 ·PubMed ·(unknown),D. De Raucourt,F. Blanchet,J. Eduardo Rame,A.M. Mandard,Aart Brutel de la Rivière,J H Jacob,Y Etienne,(unknown)	1
20	Étude de la fixation de curares à fonction ammonium quaternaire sur le mucopolysaccharide acide extrait de l'organe électrique d'electrophorus electricus et comparaison avec leur action inhibitrice sur la décharge réflexe 1962 ·Biochimica et Biophysica Acta ·G. Milhaud,C Chagas,J H Jacob,(unknown)	3

About J H Jacob

J H Jacob is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Oncology, having authored 27 papers that have together received 915 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Gastric Cancer Management and Outcomes (11 papers) and Esophageal Cancer Research and Treatment (11 papers). The work is most often cited by research in Oncology (473 citations), Pulmonary and Respiratory Medicine (504 citations) and Surgery (508 citations). J H Jacob has collaborated with scholars based in France, Luxembourg and Belgium. Frequent co-authors include Jean‐Luc Raoul, B Paillot, Harry Bleiberg, Yacine Merrouche, Étienne Dorval, Érick Gamelin, Alain Morel, Laurent Bedenne, G. Piot and R. Delva. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact